HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH]).

AuthorsPernette R W de Sauvage Nolting, Rudolf J A Buirma, Barbara A Hutten, John J P Kastelein, Dutch ExPRESS Investigator Group
JournalThe American journal of cardiology (Am J Cardiol) Vol. 90 Issue 2 Pg. 181-4 (Jul 15 2002) ISSN: 0002-9149 [Print] United States
PMID12106856 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticholesteremic Agents
  • Apolipoproteins
  • Lipoproteins
  • Triglycerides
  • Simvastatin
  • Transaminases
  • Creatine Kinase
Topics
  • Anticholesteremic Agents (administration & dosage, adverse effects)
  • Apolipoproteins (blood, drug effects)
  • Creatine Kinase (drug effects)
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperlipoproteinemia Type II (blood, drug therapy)
  • Lipoproteins (blood, drug effects)
  • Liver Function Tests
  • Male
  • Middle Aged
  • Muscular Diseases (chemically induced)
  • Simvastatin (administration & dosage, adverse effects)
  • Time Factors
  • Transaminases (drug effects)
  • Treatment Outcome
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: